Evidence map›Paper›PMID 42697996›Full record

ReviewNature methods2026

Benchmarking biomedical foundation models.

Julio Saez-Rodriguez, Philipp Sven Lars Schäfer, Nikolas Kalavros, Gustavo Stolovitzky

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Julio Saez-RodriguezEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK. saezlab@ebi.ac.uk.ORCID http://orcid.org/0000-0002-8552-8976
Philipp Sven Lars SchäferInstitute for Computational Biomedicine, Heidelberg University, Faculty of Medicine and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0009-0008-4403-8592
Nikolas KalavrosDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
Gustavo StolovitzkyDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, USA. gustavo.stolovitzky@nyulangone.org.ORCID http://orcid.org/0000-0002-9618-2819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A transparent evaluation and proof of reproducibility, generalization and replicability of algorithms are the bedrock of method development in computational biology. Many benchmarking efforts have been developed for problems ranging from structural biology to translational biomedicine. Rigor is relatively controllable for tasks such as the prediction of patient outcomes or the outcomes of biological assays, but the problem is exacerbated when the aim is to benchmark foundation models. The parameters constituting them are supposed to capture the patterns underlying the data; therefore, the models are parameterized embodiments of the phenomena that gave rise to the data. How can we test the limitations of these models? Here, we discuss the epistemological value of foundation models; whether they can be refuted, verified or evaluated primarily on the basis of utility; what principles should guide their benchmarking; and what role the scientific community should play in that benchmarking process.

Indexed as

BenchmarkingComputational BiologyAlgorithmsHumansReproducibility of Results

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.